Jane Street
ALLR

Jane Street’s Allarity Therapeutics ALLR Stock Holding History

Jane Street’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Buy
+36,021
New +$51.1K ﹤0.01% 10966
2025
Q3 		– Sell
-26,365
Closed -$26.6K – 10692
2025
Q2 		$26.6K Buy
+26,365
New +$24.9K ﹤0.01% 9313
2024
Q3 		– Sell
-522
Closed -$3.33K – 9510
2024
Q2 		$3.33K Buy
+522
New +$20.5K ﹤0.01% 9180

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street's ALLR Position: Q2 2026 in Review

Jane Street opened a new position in Allarity Therapeutics (ALLR) in Q2 2026: 36,021 shares worth $46.5K. The stake represents ﹤0.01% of the portfolio and ranks #10966 among its holdings. This is a return to the name: Jane Street previously reported a position in ALLR as recently as Q2 2025.

Jane Street first reported a position in ALLR in Q2 2024 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Jane Street held 36,021 shares of Allarity Therapeutics worth $46.5K as of Q2 2026.
  • Allarity Therapeutics was a new Jane Street position in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10966 holding.
  • Jane Street first reported a position in Allarity Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.